Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB 1 receptor-deficient mice parallel the effects of chronic stress

Cerebral Cortex

Volumn 21, Issue 9, 2011, Pages 2056-2064

  Hill, Matthew N ^a   Hillard, Cecilia J ^b   McEwen, Bruce S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

anxiety; basolateral amygdala; endocannabinoid; prefrontal cortex; stress

Indexed keywords

CANNABINOID 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CHRONIC STRESS; CONTROLLED STUDY; DENDRITIC CELL; EMOTIONALITY; IMMOBILIZATION STRESS; MALE; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DENDRITES; EMOTIONS; LIMBIC SYSTEM; MALE; MICE; MICE, KNOCKOUT; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL;

EID: 79959969118     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhq280     Document Type: Article

References (80)

1. Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzman M, Galve-Roperh I. 2005. The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19:1704-1706. (Pubitemid 41429536)
2. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. 2005. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci. 8:365-371. (Pubitemid 40300194)
3. Aso E, Ozaita A, Valdizan EM, Ledent C, Pazos A, Maldonado R, Valverde O. 2008. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem. 105:565-572. (Pubitemid 351490016)
4. Auclair N, Otani S, Soubrie P, Crepel F. 2000. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol. 83:3287-3293. (Pubitemid 30408863)
5. Ballesteros-Yanez I, Valverde O, Ledent C, Maldonado R, DeFelipe J. 2007. Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor-dependent mechanism. Neuroscience. 146:1536-1545. (Pubitemid 46783208)
6. Baran SE, Armstrong CE, Niren DC, Hanna JJ, Conrad CD. 2009. Chronic stress and sex differences on the recall of fear conditioning and extinction. Neurobiol Learn Mem. 91:323-332.
7. Barbara JG, Auclair N, Roisin MP, Otani S, Valjent E, Caboche J, Soubrie P, Crepel F. 2003. Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. Eur J Neurosci. 17:981-990. (Pubitemid 36411595)
8. Barna I, Zelena D, Arszovszki AC, Ledent C. 2004. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci. 75:2959-2970. (Pubitemid 39349260)
9. Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, Chan K, Manners MT, Samad TA, Kennedy JD, et al. 2010. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis. 39:148-155.
10. Birrell JM, Brown VJ. 2000. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci. 20:4320-4324. (Pubitemid 30365702)
11. Bloss EB, Janssen WG, McEwen BS, Morrison JH. 2010. Interactive effects of stress and aging on structural plasticity in the prefrontal cortex. J Neurosci. 30:6726-6731.
12. Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. 2008. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 33:320-331. (Pubitemid 350243351)
13. Brown SM, Henning S, Wellman CL. 2005. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb Cortex. 15:1714-1722. (Pubitemid 41447036)
14. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N. 2007. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci. 27:2781-2787. (Pubitemid 46438976)
15. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. 2007. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 370:1706-1713. (Pubitemid 350100788)
16. Cook SC, Wellman CL. 2004. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol. 60:236-248. (Pubitemid 39006996)
17. Dias-Ferreira E, Sousa JC, Melo I, Morgado P, Mesquita AR, Cerqueira JJ, Costa RM, Sousa N. 2009. Chronic stress causes frontostriatal reorganization and affects decision-making. Science. 325:621-625.
18. Feder A, Nestler EJ, Charney DS. 2009. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 10:446-457.
19. Gisquet-Verrier P, Delatour B. 2006. The role of the rat prelimbic/infralimbic cortex in working memory: not involved in the short-term maintenance but in monitoring and processing functions. Neuroscience. 141:585-596. (Pubitemid 44066650)
20. Goldwater DS, Pavlides C, Hunter RG, Bloss EB, Hof PR, McEwen BS, Morrison JH. 2009. Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. Neuroscience. 164:798-808.
21. Gorzalka BB, Hill MN, Hillard CJ. 2008. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev. 32:1152-1160.
22. Groenewegen HJ. 1988. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience. 24:379-431. (Pubitemid 18062261)
23. Hains AB, Vu MA, Maciejewski PK, van Dyck CH, Gottron M, Arnsten AF. 2009. Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc Natl Acad Sci USA. 106:17957-17962.
24. Haller J, Bakos N, Szirmay M, Ledent C, Freund TF. 2002. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci. 16:1395-1398. (Pubitemid 35340861)
25. Haller J, Varga B, Ledent C, Barna I, Freund TF. 2004. Context-dependent effects of CB1 cannabinoid gene disruption on anxietylike and social behavior in mice. Eur J Neurosci. 19:1906-1912. (Pubitemid 38482578)
26. Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, Gorzalka BB. 2008. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem. 106:2322-2336.
27. Hill MN, Gorzalka BB. 2009. Impairments in endocannabinoid signaling and depressive illness. JAMA. 301:1165-1166.
28. Hill MN, McEwen BS. 2010. Involvement of the endocannabinoid system in the neurobehavioral effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry. 34:791-797.
29. Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. 2009. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology. 34:1257-1262.
30. Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ. 2008. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 41:48-53. (Pubitemid 351427522)
31. Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. 2005. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 30:508-515. (Pubitemid 40271153)
32. Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO, Childs J, Greenberg DA. 2004. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol. 66:204-208. (Pubitemid 38989476)
33. Johnson SA, Wang JF, Sun X, McEwen BS, Chattarji S, Young LT. 2009. Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala. Neuroscience. 163:34-39.
34. Juhasz G, Chase D, Pegg E, Downey D, Toth ZG, Stones K, Platt H, Mekli K, Payton A, Elliott R, et al. 2009. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology. 34:2019-2027.
35. Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT. 2006. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci. 26:6677-6686. (Pubitemid 44315229)
36. Kim SH, Won SJ, Mao XO, Ledent C, Jin K, Greenberg DA. 2006. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogene-sis. J Pharmacol Exp Ther. 319:150-154. (Pubitemid 44455119)
37. Kolb B, Gorny G, Limebeer CL, Parker LA. 2006. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats. Synapse. 60:429-436. (Pubitemid 44380153)
38. Lacroix L, White I, Feldon J. 2002. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res. 133:69-81.
39. Lee S, Kim DH, Yoon SH, Ryu JH. 2009. Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus. Neuro-sci Lett. 467:111-116.
40. Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS. 2006. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci. 26:7870-7874. (Pubitemid 44315156)
41. Liu RJ, Aghajanian GK. 2008. Stress blunts serotonin-and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci USA. 105:359-364.
42. Magarinos AM, McEwen BS. 1995. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocor-ticoid secretion and excitatory amino acid receptors. Neuroscience. 69:89-98.
43. Maier SF, Amat J, Baratta MV, Paul E, Watkins LR. 2006. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues Clin Neurosci. 8:397-406. (Pubitemid 46102240)
44. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, et al. 2002. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 418:530-534. (Pubitemid 34851398)
45. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. 2002. Involvement of CB1 cannabinoid receptors in emotional behavior. Psychopharmacology (Berl). 159:379-387. (Pubitemid 34143362)
46. McDonald AJ, Mascagni F, Guo L. 1996. Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience. 71:55-75. (Pubitemid 26042870)
47. McEwen BS. 1999. Stress and hippocampal plasticity. Annu Rev Neurosci. 22:105-122. (Pubitemid 29144882)
48. McLaughlin KJ, Baran SE, Conrad CD. 2009. Chronic stress-and sex-specific neuromorphological and functional changes in limbic structures. Mol Neurobiol. 40:166-182.
49. Mitra R, Sapolsky RM. 2009. Effects of enrichment predominate over those of chronic stress on fear-related behavior in male rats. Stress. 12:305-312.
50. Moreira FA, Grieb M, Lutz B. 2009. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab. 23:133-144.
51. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, et al. 2008. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA. 105:8760-8765. (Pubitemid 351987753)
52. Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, Despres JP, Kastelein JJ, Steinhubl SR, Kapadia S, et al. 2008. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 299:1547-1560. (Pubitemid 351482794)
53. Patel S, Hillard CJ. 2006. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther. 318:304-311.
54. Pan B, Hillard CJ, Liu QS. 2008. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci. 28:1385-1397. (Pubitemid 351231531)
55. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. 2004. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 145:5431-5438. (Pubitemid 39564580)
56. Price JL, Drevets WC. 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology. 35:192-216.
57. Quirk GJ, Russo GK, Barron JL, Lebron K. 2000. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 20:6225-6231. (Pubitemid 30658416)
58. Radley JJ, Rocher AB, Janssen WG, Hof PR, McEwen BS, Morrison JH. 2005. Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp Neurol. 196:199-203. (Pubitemid 41416662)
59. Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH. 2004. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience. 125:1-6. (Pubitemid 38402153)
60. Reich CG, Taylor ME, McCarthy MM. 2009. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 203:264-269.
61. Rodgers RJ, Evans PM, Murphy A. 2005. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice. Behav Pharmacol. 16:405-413. (Pubitemid 41404812)
62. Roozendaal B, McEwen BS, Chattarji S. 2009. Stress, memory and the amygdala. Nat Rev Neurosci. 10:423-433.
63. Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D. 2008. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci. 28:7284-7292.
64. Sah P, Faber ES, Lopez De Armentia M, Power J. 2003. The amygdaloid complex: anatomy and physiology. Physiol Rev. 83:803-834. (Pubitemid 36828926)
65. Scheibel ME, Scheibel AB. 1970. Elementary processes in selected thalamic and cortical subsystems-the structural substrates. In: Schmitt FO, editor. The neurosciences: 2nd study program. New York: Rockefeller University Press. p. 443-457.
66. Shansky RM, Hamo C, Hof PR, McEwen BS, Morrison JH. 2009. Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb Cortex. 19:2479-2484.
67. Shin LM, Liberzon I. 2010. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 35:169-191.
68. Sibille E, Wang Y, Joeyen-Waldorf J, Gaiteri C, Surget A, Oh S, Belzung C, Tseng GC, Lewis DA. 2009. A molecular signature of depression in the amygdala. Am J Psychiatry. 166:1011-1024.
69. Sotres-Bayon F, Bush DE, LeDoux JE. 2004. Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. Learn Mem. 11:525-535. (Pubitemid 39299699)
70. Steiner MA, Marsicano G, Nestler EJ, Holsboer F, Lutz B, Wotjak CT. 2008. Antidepressant-like behavioral effects of impaired cannabi-noid receptor type 1 signaling coincide with exaggerated cortico-sterone secretion in mice. Psychoneuroendocrinology. 33:54-67.
71. Steiner MA, Marsicano G, Wotjak CT, Lutz B. 2008. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology. 33:1165-1170.
72. Swanson LW, Cowan WM. 1977. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J Comp Neurol. 172:49-84. (Pubitemid 8042578)
73. Thiemann G, Watt CA, Ledent C, Molleman A, Hasenohrl RU. 2009. Modulation of anxiety by acute blockade and genetic deletion of the CB (1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav Brain Res. 200:60-67.
74. Varvel SA, Anum EA, Lichtman AH. 2005. Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psycho-pharmacology (Berl). 179:863-872. (Pubitemid 40767906)
75. Varvel SA, Lichtman AH. 2002. Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther. 301:915-924. (Pubitemid 34595080)
76. Vyas A, Jadhav S, Chattarji S. 2006. Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala. Neuroscience. 143:387-393. (Pubitemid 44716592)
77. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. 2002. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 22:6810-6818. (Pubitemid 35386438)
78. Vyas A, Pillai AG, Chattarji S. 2004. Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxietylike behavior. Neuroscience. 128:667-673. (Pubitemid 39298420)
79. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. 2007. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci. 27:684-691. (Pubitemid 46143772)
80. Zoppi S, Perez Nievas BG, Madrigal JL, Manzanares J, Leza JC, Garci-Bueno B. 2010. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychophar-macology. doi: 10.1038/npp.2010.214.